|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 257.85 USD | +1.91% |
|
+4.92% | +1.63% |
| Capitalization | 31.01B 26.66B 24.97B 23.28B 42.99B 2,791B 46.76B 292B 113B 1,318B 116B 114B 4,820B | P/E ratio 2025 * |
20.5x | P/E ratio 2026 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise value | 38.8B 33.36B 31.25B 29.13B 53.8B 3,492B 58.51B 365B 141B 1,649B 146B 143B 6,031B | EV / Sales 2025 * |
0.3x | EV / Sales 2026 * | 0.27x |
| Free-Float |
60.46% | Yield 2025 * |
1.42% | Yield 2026 * | 1.54% |
Last Transcript: Humana Inc.
| 1 day | +1.91% | ||
| 1 week | +4.92% | ||
| Current month | +4.92% | ||
| 1 month | -2.68% | ||
| 3 months | -16.26% | ||
| 6 months | +13.51% | ||
| Current year | +1.63% |
| 1 week | 238.81 |  | 264.8 |
| 1 month | 221.5 | | 264.8 |
| Current year | 206.87 | | 315.35 |
| 1 year | 206.87 | | 315.35 |
| 3 years | 206.87 | | 553.69 |
| 5 years | 206.87 | | 571.3 |
| 10 years | 150 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 54 | 2024-06-30 |
Celeste Brown
DFI | Director of Finance/CFO | 48 | 2025-01-10 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 44 | 2025-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 64 | 2013-12-31 |
Frank D'Amelio
BRD | Director/Board Member | 67 | 2003-08-31 |
Karen Katz
BRD | Director/Board Member | 68 | 2019-09-22 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.3% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.91% | +4.92% | -8.91% | -52.90% | 31.01B | |
| -0.77% | +0.35% | -42.85% | -38.15% | 300B | |
| -0.31% | -2.22% | -15.84% | -36.68% | 73.51B | |
| -1.11% | -4.27% | -17.72% | -18.92% | 70.91B | |
| -1.31% | -2.54% | -33.84% | -55.60% | 18.84B | |
| +0.86% | +2.43% | -49.45% | -54.68% | 7.81B | |
| +0.77% | +1.77% | +60.25% | +50.97% | 3.91B | |
| -0.54% | -8.91% | +60.13% | -29.50% | 2.07B | |
| -3.01% | +3.61% | -24.56% | +104.76% | 1.33B | |
| -0.17% | -1.03% | -20.30% | - | 388M | |
| Average | -0.16% | -0.70% | -9.31% | -14.52% | 50.95B | |
| Weighted average by Cap. | +0.48% | -0.48% | -31.88% | -35.96% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 129B 111B 104B 96.94B 179B 11,624B 195B 1,217B 470B 5,490B 485B 474B 20,073B | 143B 123B 115B 108B 199B 12,896B 216B 1,350B 521B 6,091B 538B 526B 22,270B |
| Net income | 1.51B 1.3B 1.21B 1.13B 2.09B 136B 2.28B 14.21B 5.49B 64.13B 5.66B 5.54B 234B | 1.47B 1.26B 1.18B 1.1B 2.03B 132B 2.21B 13.81B 5.33B 62.32B 5.5B 5.38B 228B |
| Net Debt | 7.79B 6.7B 6.27B 5.85B 10.8B 701B 11.75B 73.4B 28.34B 331B 29.25B 28.62B 1,211B | 7.66B 6.59B 6.17B 5.75B 10.62B 690B 11.56B 72.18B 27.87B 326B 28.76B 28.15B 1,191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 257.85 $ | +1.91% | 1,627,163 |
| 25-12-04 | 253.02 $ | -1.52% | 2,097,377 |
| 25-12-03 | 256.92 $ | +6.18% | 2,531,071 |
| 25-12-02 | 241.96 $ | -0.11% | 1,696,598 |
| 25-12-01 | 242.23 $ | -1.44% | 1,623,567 |
Delayed Quote Nyse, December 05, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition